Cargando…

Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia

Detalles Bibliográficos
Autores principales:	Li, Quanfu, Jin, Gaowa, Jiang, Caihong, Zhang, Zewei, Hou, Jixiang, Zhao, Juan, Chen, Feng, Li, Zhenhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425230/ https://www.ncbi.nlm.nih.gov/pubmed/34522277 http://dx.doi.org/10.5114/aoms/141134

Ejemplares similares

Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy
por: Chen, Li, et al.
Publicado: (2019)

Dynamic changes in the body composition during chemotherapy for gastrointestinal tumors in the context of active nutrition intervention
por: Xu, Ting, et al.
Publicado: (2022)

The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer
por: Chen, Jun-Bing, et al.
Publicado: (2022)

Oral manifestations of thrombocytopaenia
por: Khammissa, R.A.G., et al.
Publicado: (2018)

Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients
por: Yu, Shan, et al.
Publicado: (2020)

Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
por: Tian, Yuan, et al.
Publicado: (2021)

Foetal and neonatal alloimmune thrombocytopaenia
por: Kaplan, Cecile
Publicado: (2006)

Efficacy of Different Number of XELOX or SOX Chemotherapy Cycles After D2 Resection for Stage III Gastric Cancer
por: Yu, Yuanyuan, et al.
Publicado: (2022)

A Comparison of the Efficacy of 5 mg Olanzapine and Aprepitant in the Prevention of Multiple-Day Cisplatin Chemotherapy-Induced Nausea and Vomiting
por: Liu, Guang, et al.
Publicado: (2022)

Anaesthetic management of parturient with malaria and thrombocytopaenia
por: Khanna, Ashish, et al.
Publicado: (2016)

Severe thrombocytopaenia secondary to COVID-19
por: Patel, Trupesh, et al.
Publicado: (2020)

Mitochondrial energy metabolism correlates with an immunosuppressive tumor microenvironment and poor prognosis in esophageal squamous cell carcinoma
por: Zhang, Zewei, et al.
Publicado: (2023)

Efficacy of Postoperative FOLFOX Versus XELOX Chemotherapy for Gastric Cancer and Prognostic Value of Platelet–Lymphocyte Ratio in Patients Receiving XELOX
por: Yin, Xin, et al.
Publicado: (2020)

Immunomodulatory cytokine interleukin-35 and immune thrombocytopaenia
por: Zhu, Jing-Jing, et al.
Publicado: (2020)

Azd-1222: Immune thrombocytopaenia: case report
Publicado: (2022)

Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school
por: Ungari, Andrea Queiróz, et al.
Publicado: (2017)

A randomized trial evaluating the association between related gene polymorphism and nausea and vomiting induced by cisplatin multi-day chemotherapy
por: Jin, Yilan, et al.
Publicado: (2023)

Thrombocytopaenia in pregnant women with malaria on the Thai-Burmese border
por: Tan, Saw Oo, et al.
Publicado: (2008)

Gestational thrombocytopaenia among pregnant women in Lagos, Nigeria
por: Ajibola, Sarah Oluwatayo, et al.
Publicado: (2014)

Impact of COVID-19 Pandemic on Patients with Immune Thrombocytopaenia
por: Román, María-Teresa Álvarez, et al.
Publicado: (2021)

Azd-1222: Immune thrombosis with thrombocytopaenia: case report
Publicado: (2021)

Prolactinoma with apoplexy in the context of thrombocytopaenia: A case report
por: Chow, Oliver, et al.
Publicado: (2022)

PEGylated thrombopoietin mimetic, JNJ‑26366821 a novel prophylactic radiation countermeasure for acute radiation injury
por: Holmes-Hampton, Gregory P., et al.
Publicado: (2023)

Clinical efficacy of neoadjuvant chemotherapy regimens FLEEOX vs. XELOX in patients with initially unresectable advanced gastric cancer: a propensity score analysis
por: Li, Yang, et al.
Publicado: (2017)

Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis
por: Zhang, Dan, et al.
Publicado: (2018)

Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX)
por: Wang, Yan, et al.
Publicado: (2016)

Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation
por: Wang, Chao, et al.
Publicado: (2015)

XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)
por: Zhu, Xiao‐Dong, et al.
Publicado: (2022)

Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience
por: Peng, Jianhong, et al.
Publicado: (2019)

Heparin-induced thrombocytopaenia presenting as acute aortic mural thrombosis
por: Bienz, Maya Joanne, et al.
Publicado: (2018)

Platelet transfusion for neonates with thrombocytopaenia: protocol for a systematic review
por: Liu, Dengjun, et al.
Publicado: (2020)

Vaccine-induced immune thrombosis and thrombocytopaenia: incidence, mechanism and treatment
por: Hrastelj, J., et al.
Publicado: (2021)

The Importance of Platelet Glycoside Residues in the Haemostasis of Patients with Immune Thrombocytopaenia
por: Ramírez-López, Andrés, et al.
Publicado: (2021)

Multiterritorial strokes in the setting of spontaneous heparin-induced thrombocytopaenia syndrome
por: Kwan, Christopher, et al.
Publicado: (2022)

Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery
por: Abdel-Meguid, Mohamed Essam
Publicado: (2013)

An Update in Our Understanding of the Relationships Between Gene Polymorphisms and Chemotherapy-Induced Nausea and Vomiting
por: Jin, Yilan, et al.
Publicado: (2021)

Switching between eltrombopag and recombinant human thrombopoietin in patients with immune thrombocytopenia: an observational study
por: Cai, Xuan, et al.
Publicado: (2022)

Overproduction of thrombopoietin by BRAFV600E‐mutated mouse hepatocytes and contribution of thrombopoietin to hepatocarcinogenesis
por: Tanaka, Hiroki, et al.
Publicado: (2019)

Administration of recombinant human thrombopoietin is associated with alleviated thrombocytopenia in adult intensive care unit patients with pneumonia: A single-center retrospective study
por: Chen, Bailiang, et al.
Publicado: (2022)

Management of colorectal cancer liver metastasis in a patient with immune thrombocytopaenia
por: Yacob, M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g3h9915l4lcip83o5hq934e2qg